Xeris Biopharma Holdings Inc (XERS)
CapEx to Revenue
0.23%
Quarterly · Period ending:
XERS CapEx to Revenue
Latest reported0.23%period ending
Latest reported0.23%period ending
XERS Quarterly CapEx/Revenue (96.61% → 0.23%)
Latest values, visible window
High-resolution chart · PNG
XERS capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0.2269% | |
| 0.391% | |
| 0.3881% | |
| 0.488% | |
| 0.39% | |
| 0.0216% | |
| 0.3661% | |
| 0.1603% | |
| 0.826% | |
| 0.4036% | |
| 0.2974% | |
| 0.714% | |
| 4.0728% | |
| 0.717% | |
| 0.3983% | |
| 0.5921% | |
| 0.8536% | |
| 0% | |
| 0.6046% | |
| 2.7821% | |
| 2.4478% | |
| 5.2349% | |
| 3.1372% | |
| 0% | |
| 7.2028% | |
| 1.4541% | |
| 13.0901% | |
| 114.2415% | |
| 91.875% | |
| 80.6452% | |
| 31.211% | |
| 132.4742% | |
| 19.0476% | |
| 126.616% | |
| 50.5353% | |
| 14.7059% | |
| 17.1681% | |
| 96.6102% |